The pharmaceutical companies under the collection speed up the digital layout and resolve the cost pressure.

Pharmaceutical Network Industry Dynamics: At present, the third batch of tape procurement has been "arrow on the string" industry generally expected the third batch of decline or will be higher than the second batchWith the collection of normal drug price reduction has become a trend of production enterprises will face great pressureIn order to solve the cost conundrum in recent years, many pharmaceutical companies have accelerated digital layout in order to increase efficiency and reduce costsFor example, Xiang Xue Pharmaceutical stoue has announced that it has launched a digital operating platform construction project with a domestic enterprise cloud service and software providerAccording to the introduction of the two together this is a strategic level of comprehensive cooperation is intended to work together to create a new benchmark for digital empowerment of the pharmaceutical industryIt is reported that the two sides not only in the financial, supply chain, procurement, marketing, manpower and other aspects of digital upgrading to create a new cross-company, cross-regional business system sesame business real-time but also to use the big data analytics platform to understand who users, user preferences and other core issues of enterprise developmentThe pharmaceutical company's officials said the digital operation platform after the horse only financial personnel costs are expected to be savedAnd that doesn't include a drop in procurement costs after the picksWith big data tips every day market new, comprehensive supply and demand news procurement costs will hopefully be reducedYuekang Pharmaceuticals is working with Huawei to build a "Yukang Cloud" service platform using its leading cloud computing technology to help it achieve digital transformation and upgrade the development of innovative business development such as Internet and HealthLunan Pharmaceuticals is also embracing the digital waveIt is understood that in recent years, Lunan Pharmaceuticals to customer demand as the center of technology as a means to data-based assets to build a rapid customer demand to meet customer needs of the technology platform system to support customer service and business innovationIn the industry's view this year by the impact of the special period of the Internet digital economy ushered in a lot of growth points, especially Internet healthcare played a key role in the rapid developmentIn this context, domestic support for digital medical construction is also increasing and constantly improving the construction of population health information service system and promoting the application of health care big dataFor the current pharmaceutical companies, especially on the demand side of the head pharmaceutical enterprises with the two-vote system, generic drug consistency evaluation, "plus" band procurement and other series of policies to introduce control fee reduction is the challenge that enterprises have to face its digital transformation has become a general trendAt the same time, the author notes that the digital transformation service providers of pharmaceutical enterprises are also attracting the attention of the capital market Recently, Mingdu Wisdom announced the completion of the million plus round of financing The company focuses on the pharmaceutical industry for large pharmaceutical companies from research and development to production, warehousing logistics digital transformation services The relevant person in charge of the company pointed out that for a long time the pharmaceutical industry in the completion of drug machine automation, improvement in information technology, intelligent construction of slow progress compared to the United States, Japan, the European Union and other Chinese pharmaceutical industry in the pharmaceutical enterprise wisdom upgrade, compliance management and other aspects have great room for improvement;